Emerging HIV treatment options were at the forefront of CROI 2021. Here are my key takeaways from some of the most intriguing presentations.
Highly anticipated data on long-acting PrEP options in development were presented at CROI 2021. Here are my interpretations of these data and considerations for future implementation.
Hear insights from Chloe Orkin, MBChB, FRCP, MD, on exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.
In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important annual conference, including new data on the following hot topics: HIV PrEP strategies; ART in pregnancy, the postpartum period, children and adolescents; racial disparities in COVID-19 outcomes among PWH; HIV and coinfections/comorbidities; and current and investigational ART.
Data presented at CROI 2021 show that the COVID-19 pandemic has disrupted health systems around the world, affecting diagnosis and treatment of HIV and other diseases, especially in low- and middle-income countries.
My take on data from several Kenyan studies presented at CROI 2021, including analyses of STI incidence among girls and young women and investigations into factors associated with and strategies for promoting improved PrEP uptake.
Data on long-acting ART continued to dominate the presentations at CROI 2021. Here are my thoughts on the practicalities of potentially integrating these new drugs into my practice in Canada.
My picks for interesting HIV treatment data presented at CROI 2021 include 2 studies performed in Spain, one comparing the efficacy of fixed-dose boosted PI combination ART vs second-generation integrase inhibitors and one investigating treatment options for newly diagnosed patients with advanced HIV.
My pick for data presented at CROI 2021 is a study comparing post-ART weight gain in people with HIV in Latin America vs Latinx people with HIV in the United States and Canada.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.